5,6,7,8-tetrahydronaphthalen-2-yl-7-fluoroalkyl-heptatrienoic acid derivatives having serum glucose reducing activity

   
   

Compounds of the formula ##STR1##

where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effect of reducing serum thyroxine levels.

 
Web www.patentalert.com

< Neuropathy remedies

< Human G-Protein chemokine receptor HDGNR10 (CCR5 receptor)

> Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same

> Cyclic hexapeptides having antibiotic activity

~ 00176